BRIEF-Novo Nordisk to resubmit U.S. new drug applications for Tresiba and Ryzodeg
March 26, 2015 at 12:29 PM EDT
* Has decided to resubmit the new drug applications of Tresiba and Ryzodeg in the U.S.Source text for Eikon: Further company coverage: (Reporting By Ben Hirschler)
